Bill Cherman

About Bill Cherman

Bill is a co-founder of Repair Biotechnologies, a startup developing therapies for thymus regeneration and atherosclerosis reversal, and also a partner at Front Seat Capital, where he leads investments in longevity startups. Previously, he previously worked as a consultant at McKinsey & Company an American worldwide management consulting firm.

Related Organizations

Retroviruses Contribute to the Spread of Cellular Senescence
Scientists have found that the remnants of the ancient retrovirus family HERVK, which reside in our genome, are transcribed more frequently in aged cells. This is caused by […]
Diagnosing Alzheimer’s in the Near Infrared
In Nature Biomedical Engineering, a team of researchers has published an innovative method of making tau tangles and amyloid beta visible in the near infrared, allowing doctors and researchers to see […]
Is Increasing Human Lifespan Unnatural?
Whenever the topic of any possible increased healthy longevity through science is discussed, a common objection to developing the technology is that it is unnatural. This argument usually arises during discussions of […]

Red Blood Cells as Biomarkers of Aging
The advent of artificial intelligence and its application to the study of aging and longevity took a giant leap forward in 2013 with the development of tools for measuring biological age. Public access to these […]
The Relationship Between ApoE and Alzheimer’s
Alzheimer’s disease is the most typical form of dementia. It is a progressive disease that begins with mild memory loss, leads to profound cognitive deficits, and ends with death. 10% to 14% of adults over 65 have […]
Bio.xyz: a DAO for Building Other Biotech DAOs
It’s only been a couple of months since Molecule announced the formation of its latest DAO project, bio.xyz, to the world. However, the newly formed DAO is […]

Menu

About Bill Cherman

Related Organizations

Stay in the know

Menu

Bill Cherman

About Bill Cherman

Related Organizations

Register